Celltrion Progresses COVID-19 Antibody Therapeutic, Pricing Will Be Key
Executive Summary
Celltrion presses ahead with Phase I study of COVID-19 antibody therapeutic, encouraged by the support of the South Korean government. The firm also urges global cooperation to lower prices of COVID-19 drugs and vaccines to end the global pandemic.